Further, the authors found that the NFκB pathway was central to the chemokine axis driving GBM growth and conditional deletion of the p65 subunit of the NFκB transcription factor inhibited GBM tumor growth in an immune competent model, suggesting a critical role of inflammation in GBM pathogenesis [40]. The gene discussed is NFKB1; the disease is glioblastoma.